s6y
Company name or ticker
Search
Tempest Therapeutics, Inc.
3
Frederick John W.: Initial statement of beneficial ownership of securities
Filed
Monday, November 2, 2026
Period
Oct 13, 2026
Accession number
0001213900-26-114956
Documents
OWNERSHIP DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header